Illumina, Inc. (NASDAQ:ILMN) showed strong performance with a 23.4% rally after exceeding earnings guidance. CEO Jacob Thaysen highlighted revenue growth in the clinical segment. The company revised its revenue decline projection for fiscal year 2025 to 0.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing